Mubadala Expands Healthcare Logistics With Majority Stake In Global Medical Supply Chain And Al Ittihad Drug

Mubadala Investment Company has taken an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), which retains a 20% share. This move strengthens Mubadala's presence in healthcare logistics and pharmaceutical distribution, supporting the UAE's goal of building a strong life sciences infrastructure.

Founded in 2015, GMSC offers complete supply chain services for medical products. These services include demand planning, procurement, logistics, inventory management, warehousing, and maintenance. GMSC supports over 200 medical facilities like hospitals and clinics throughout the UAE. With a team of specialists, they source products from nearly 400 suppliers to ensure a dependable supply chain.

IDS, established in 1987, is a major distributor of pharmaceutical and consumer healthcare products in the UAE. It distributes more than 1,000 products from over 40 leading suppliers. IDS serves every hospital and most pharmacies and supermarkets within the UAE. Its portfolio covers various therapeutic areas such as anti-infectives, asthma, diabetes, and oncology.

Ismail Ali Abdulla, Executive Director of UAE Clusters at Mubadala's UAE Investments Platform, stated that the growing pharmaceutical market increases demand for specialised drug logistics solutions. "By integrating GMSC and IDS into our portfolio," he said, "we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialised manufacturing."

Low Ping, Group CEO Yas Holding, remarked on Mubadala's strategic growth through this transaction. It follows another acquisition by its new speciality pharmaceutical business KELIX bio. KELIX bio recently acquired four pharma assets entirely from GlobalOne Healthcare Holding's healthcare division of Yas Holding. These efforts highlight Mubadala's dedication to enhancing the UAE's healthcare and pharmaceutical sectors as part of national goals for drug security and economic diversification.

GlobalOne Healthcare Holding LLC is Yas Holding LLC's dedicated Healthcare Division. It focuses on improving healthcare outcomes by investing in innovative solutions across different healthcare verticals.

This acquisition marks a significant step for Mubadala towards establishing a comprehensive life sciences sector in the UAE. By expanding its reach in healthcare logistics and pharmaceuticals, Mubadala aligns with broader national ambitions for economic growth and drug security.

With inputs from WAM